Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 16, 2021
Patent Application Number
17140321
Date Filed
January 4, 2021
Patent Primary Examiner
Patent abstract
Described herein are diagnostic and control fusion protein reagents and methods for use thereof in simple rapid and inexpensive hemagglutinin assays for the detection of subject antibodies directed to the SARS-CoV-2 virus.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.